Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$3.40
0.4314.48%
al cierre: Nov 26, 4:00 PM EST
$3.40
0.0010.03%
After hour: 7:58 PM EST
Comments
Loading...
Petco Health and Wellness Calificaciones de analistas
WOOFNASDAQ
Calificaciones de analistas, precios objetivo, pronóstico
Petco Health and Wellness Co Inc tiene un precio objetivo de consenso de $4.26 basado en las calificaciones de 16 analistas. El máximo es $10, emitido por Gordon Haskett el abril 28, 2023. El mínimo es $1.5, emitido por B of A Securities el abril 2, 2024. Las 3 calificaciones de analistas más recientes fueron publicadas por Evercore ISI Group, RBC Capital y Jefferies el noviembre 26, 2025, septiembre 3, 2025 y agosto 29, 2025, respectivamente. Con un precio objetivo promedio de $4.05 entre Evercore ISI Group, RBC Capital y Jefferies, hay una 19.08% upside implícita para Petco Health and Wellness Co Inc según estas calificaciones más recientes de analistas.
Firmas de analistas que realizan recomendaciones1
Evercore ISI Group
RBC Capital
Jefferies
UBS
Wells Fargo
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Petco Health and Wellness
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/26/2025 | 17.61% | Evercore ISI Group | $3 → $4 | Maintains | In-Line | |||
09/03/2025 | 17.61% | RBC Capital | $4 → $4 | Reiterates | Outperform → Outperform | |||
09/02/2025 | — | Guggenheim | — | Reiterates | Neutral → Neutral | |||
08/29/2025 | 22.02% | Jefferies | $4.05 → $4.15 | Maintains | Hold | |||
08/29/2025 | 8.79% | UBS | $3.25 → $3.7 | Maintains | Neutral | |||
08/29/2025 | 17.61% | Wells Fargo | $3.5 → $4 | Maintains | Equal-Weight | |||
08/29/2025 | 17.61% | Baird | $3.5 → $4 | Maintains | Neutral | |||
06/06/2025 | 32.31% | Morgan Stanley | $5 → $4.5 | Maintains | Equal-Weight | |||
06/06/2025 | 2.91% | Wells Fargo | $3 → $3.5 | Maintains | Equal-Weight | |||
03/27/2025 | 31.73% | Goldman Sachs | $4 → $4.48 | Maintains | Buy | |||
03/27/2025 | -4.44% | UBS | $5.5 → $3.25 | Maintains | Neutral | |||
03/27/2025 | 17.61% | RBC Capital | $6 → $4 | Maintains | Outperform | |||
03/27/2025 | 17.61% | Wedbush | $6 → $4 | Maintains | Outperform | |||
03/27/2025 | 2.91% | Baird | $5 → $3.5 | Maintains | Neutral | |||
03/18/2025 | -19.14% | Citigroup | $5 → $2.75 | Maintains | Neutral | |||
02/24/2025 | -11.79% | Wells Fargo | $5 → $3 | Maintains | Equal-Weight | |||
01/21/2025 | 47.02% | Morgan Stanley | $6 → $5 | Maintains | Equal-Weight | |||
12/20/2024 | 76.42% | RBC Capital | $6 → $6 | Reiterates | Outperform → Outperform | |||
12/06/2024 | 76.42% | Wedbush | $5.5 → $6 | Maintains | Outperform | |||
12/06/2024 | 76.42% | Morgan Stanley | $3 → $6 | Maintains | Equal-Weight | |||
12/06/2024 | 76.42% | RBC Capital | $5 → $6 | Maintains | Outperform | |||
12/06/2024 | 47.02% | Wells Fargo | $3 → $5 | Maintains | Equal-Weight | |||
10/18/2024 | 61.72% | Wedbush | $5 → $5.5 | Maintains | Outperform | |||
09/12/2024 | 32.31% | Citigroup | $4 → $4.5 | Maintains | Neutral | |||
09/12/2024 | 17.61% | Goldman Sachs | $5 → $4 | Maintains | Buy | |||
09/11/2024 | 2.91% | RBC Capital | $3 → $3.5 | Maintains | Outperform | |||
09/11/2024 | -11.79% | Wells Fargo | $2.75 → $3 | Maintains | Equal-Weight | |||
09/11/2024 | 47.02% | Wedbush | $5 → $5 | Reiterates | Outperform → Outperform | |||
07/19/2024 | 17.61% | Citigroup | $3 → $4 | Maintains | Neutral | |||
07/18/2024 | 47.02% | Wedbush | $4 → $5 | Maintains | Outperform | |||
05/29/2024 | 17.61% | Wedbush | $4 → $4 | Reiterates | Outperform → Outperform | |||
05/24/2024 | -11.79% | RBC Capital | $2.7 → $3 | Maintains | Outperform | |||
05/23/2024 | 47.02% | Needham | $5 → $5 | Reiterates | Buy → Buy | |||
05/23/2024 | 17.61% | Wedbush | $3 → $4 | Maintains | Outperform | |||
05/23/2024 | -4.44% | UBS | $2.5 → $3.25 | Maintains | Neutral | |||
05/07/2024 | -48.54% | Citigroup | $2.85 → $1.75 | Maintains | Neutral | |||
04/02/2024 | -55.9% | B of A Securities | $5 → $1.5 | Downgrade | Buy → Underperform | |||
03/25/2024 | -41.19% | Wells Fargo | $3 → $2 | Maintains | Equal-Weight | |||
03/20/2024 | -26.49% | UBS | $3 → $2.5 | Maintains | Neutral | |||
03/15/2024 | -20.61% | RBC Capital | $3.5 → $2.7 | Maintains | Outperform | |||
03/15/2024 | -11.79% | Evercore ISI Group | $4 → $3 | Maintains | In-Line | |||
03/14/2024 | -26.49% | Baird | $3 → $2.5 | Maintains | Neutral | |||
03/13/2024 | 47.02% | Needham | $5 → $5 | Maintains | Buy | |||
12/19/2023 | -8.56% | Jefferies | → $3.11 | Initiates | → Hold | |||
12/04/2023 | -11.79% | Morgan Stanley | $5 → $3 | Maintains | Equal-Weight | |||
12/04/2023 | 2.91% | RBC Capital | $7 → $3.5 | Maintains | Outperform | |||
11/30/2023 | 47.02% | Goldman Sachs | $7 → $5 | Maintains | Buy | |||
11/30/2023 | 2.91% | Wedbush | $4.5 → $3.5 | Maintains | Outperform | |||
11/29/2023 | 47.02% | Needham | $8 → $5 | Maintains | Buy | |||
11/29/2023 | — | Wells Fargo | — | Downgrade | Overweight → Equal-Weight | |||
10/31/2023 | 32.31% | Wedbush | $6 → $4.5 | Maintains | Outperform | |||
09/29/2023 | — | Wolfe Research | — | Initiates | → Peer Perform | |||
09/08/2023 | 135.22% | Evercore ISI Group | $6 → $8 | Maintains | In-Line | |||
08/25/2023 | 194.03% | B of A Securities | $12 → $10 | Maintains | Buy | |||
08/25/2023 | 47.02% | Morgan Stanley | $9 → $5 | Maintains | Equal-Weight | |||
08/25/2023 | 105.82% | RBC Capital | $10 → $7 | Maintains | Outperform | |||
08/25/2023 | 76.42% | Wedbush | $9 → $6 | Maintains | Outperform | |||
08/25/2023 | 105.82% | Wells Fargo | $11 → $7 | Maintains | Overweight | |||
08/25/2023 | 135.22% | Needham | $12 → $8 | Maintains | Buy | |||
08/16/2023 | 164.63% | Wedbush | $10 → $9 | Maintains | Outperform | |||
05/26/2023 | 252.84% | B of A Securities | $14.5 → $12 | Maintains | Buy | |||
05/26/2023 | 194.03% | RBC Capital | → $10 | Reiterates | Outperform → Outperform | |||
05/25/2023 | 164.63% | Morgan Stanley | $10 → $9 | Maintains | Equal-Weight | |||
05/24/2023 | 252.84% | Needham | $15 → $12 | Maintains | Buy | |||
05/22/2023 | 223.43% | Wedbush | → $11 | Reiterates | Outperform → Outperform | |||
04/28/2023 | 194.03% | Gordon Haskett | → $10 | Initiates | → Hold | |||
04/14/2023 | 341.05% | Needham | $20 → $15 | Maintains | Buy | |||
03/29/2023 | 326.35% | B of A Securities | $18 → $14.5 | Maintains | Buy | |||
03/28/2023 | 149.93% | Citigroup | $11 → $8.5 | Maintains | Neutral | |||
03/23/2023 | 194.03% | Evercore ISI Group | $12 → $10 | Maintains | In-Line | |||
03/23/2023 | 194.03% | RBC Capital | $14 → $10 | Maintains | Outperform | |||
03/23/2023 | 194.03% | Morgan Stanley | $12 → $10 | Maintains | Equal-Weight | |||
03/23/2023 | 223.43% | Baird | $14 → $11 | Maintains | Outperform | |||
03/23/2023 | 488.06% | Needham | → $20 | Reiterates | → Buy | |||
03/15/2023 | 252.84% | Wells Fargo | $14 → $12 | Maintains | Overweight | |||
03/13/2023 | 223.43% | Citigroup | → $11 | Downgrade | Buy → Neutral | |||
02/09/2023 | 311.64% | RBC Capital | → $14 | Reiterates | → Outperform | |||
01/17/2023 | 252.84% | Morgan Stanley | $14 → $12 | Maintains | Equal-Weight | |||
12/02/2022 | 311.64% | Morgan Stanley | $19 → $14 | Maintains | Equal-Weight | |||
12/01/2022 | 370.45% | Goldman Sachs | $18 → $16 | Maintains | Buy | |||
12/01/2022 | 370.45% | RBC Capital | $17 → $16 | Maintains | Outperform | |||
12/01/2022 | 252.84% | UBS | $16 → $12 | Maintains | Neutral | |||
11/28/2022 | 488.06% | Needham | $30 → $20 | Maintains | Buy |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Petco Health and Wellness (WOOF)?
El último precio objetivo de Petco Health and Wellness (NASDAQ:WOOF) fue comunicado por Evercore ISI Group el noviembre 26, 2025. La firma de analistas fijó un precio objetivo para $4.00 que espera WOOF a rise dentro de 12 meses (un posible 17.61% upside). 22 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Petco Health and Wellness (WOOF)?
La última calificación de analistas para Petco Health and Wellness (NASDAQ:WOOF) fue proporcionada por Evercore ISI Group, y Petco Health and Wellness mantuvo su in-line calificación.
¿Cuándo se produjo la última revisión al alza de Petco Health and Wellness (WOOF)?
No hay última actualización para Petco Health and Wellness
¿Cuándo fue la última revisión a la baja de Petco Health and Wellness (WOOF)?
La última revisión a la baja de Petco Health and Wellness Co Inc se produjo en abril 2, 2024, cuando B of A Securities cambió su precio objetivo de $5 a $1.5 para Petco Health and Wellness Co Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Petco Health and Wellness (WOOF)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Petco Health and Wellness, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Petco Health and Wellness se registró el noviembre 26, 2025, por lo que la próxima calificación estará disponible en torno al noviembre 26, 2026.
¿Es correcta la calificación de los analistas sobre Petco Health and Wellness (WOOF)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Petco Health and Wellness (WOOF) fue un mantuvo con un precio objetivo de $3.00 a $4.00. El precio actual al que cotiza Petco Health and Wellness (WOOF) es de $3.40, que es within del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.